Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for TC BioPharm (Holdings) PLC Sponsored ADR (TCBPY : OTC)

• Company Description    TC BioPharm plc is a clinical stage biotechnology company developing platform allogeneic gamma-delta T cell therapies for cancer and viral indications. TC BioPharm plc is based in EDINBURGH, Scotland. Number of Employees: 39

• Price / Volume Information    Yesterday's Closing Price: $0.27 Daily Weekly Monthly 20 Day Moving Average: 6,811 shares Shares Outstanding: 0.41 (millions) Market Capitalization: $0.11 (millions) Beta: 0.48 52 Week High: $9.43 52 Week Low: $0.16 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week -20.59% -23.56% 12 Week -44.88% -53.63% Year To Date -97.38% -97.55%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL MAXIM 1 2 PARKLANDS WAY - HOLYTOWN,X0 ML14WR GBR ph: 44-14-1433-7557 fax: - ir@tcbiopharm.com http://www.tcbiopharm.com

• General Corporate Information    Officers Bryan Kobel - Chief Executive Officer Arlene Morris - Chairman and Director Martin Thorp - Chief Financial Officer James Culverwell - Director Edward Niemczyk - Director Peer Information - (-) - (-) - (-) - (-) - (-) - (-) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED-BIOMED/GENE Sector: Medical CUSIP: 87807D608 SIC: 2836 Fiscal Year Fiscal Year End: December Last Reported Quarter: - Next Expected EPS Date: - Share - Related Items Shares Outstanding: 0.41 Most Recent Split Date: 2.00 (0.05:1) Beta: 0.48 Market Capitalization: $0.11 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $ Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $ Payout Ratio: Number of Estimates in the Fiscal Year Consensus: Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: -

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: 0.03 Price/Cash Flow: - Price / Sales: - EPS Growth vs. Year Ago Period: -% vs. Previous Quarter: -% Sales Growth vs. Year Ago Period: -% vs. Previous Quarter: -% ROE 06/30/25 - - 03/31/25 - - 12/31/24 - - ROA 06/30/25 - - 03/31/25 - - 12/31/24 - - Current Ratio 06/30/25 - - 03/31/25 - - 12/31/24 - 1.39 Quick Ratio 06/30/25 - - 03/31/25 - - 12/31/24 - 1.39 Operating Margin 06/30/25 - - 03/31/25 - - 12/31/24 - - Net Margin 06/30/25 - - 03/31/25 - - 12/31/24 - - Pre-Tax Margin 06/30/25 - - 03/31/25 - - 12/31/24 - - Book Value 06/30/25 - - 03/31/25 - - 12/31/24 - 9.37 Inventory Turnover 06/30/25 - - 03/31/25 - - 12/31/24 - - Debt-to-Equity 06/30/25 - - 03/31/25 - - 12/31/24 - 0.39 Debt-to-Capital 06/30/25 - - 03/31/25 - - 12/31/24 - 28.00

Powered by Zacks Investment Research ©